Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Dec;21(6):965-72.
doi: 10.3346/jkms.2006.21.6.965.

Pretreatment with N-nitro-L-arginine methyl ester improved oxygenation after inhalation of nitric oxide in newborn piglets with Escherichia coli pneumonia and sepsis

Affiliations

Pretreatment with N-nitro-L-arginine methyl ester improved oxygenation after inhalation of nitric oxide in newborn piglets with Escherichia coli pneumonia and sepsis

Yun Sil Chang et al. J Korean Med Sci. 2006 Dec.

Abstract

We evaluated the effects of a combined therapy of pre-blockade endogenous nitric oxide synthase (NOS) with N-nitro-L-arginine methyl ester (L-NAME) and continuous inhaled NO (iNO) on the gas exchange and hemodynamics of Escherichia coli pneumonia and sepsis in newborn piglets. Seven to ten day old ventilated newborn piglets were randomized into 5 groups: control, E. coli pneumonia control, pneumonia with iNO 10 ppm, pneumonia pre-treated with L-NAME 10 mg/kg, and pneumonia with the combined therapy of L-NAME pretreatment and iNO. E. coli pneumonia was induced via intratracheal instillation of Escherichia coli, which resulted in progressively decreased cardiac index and oxygen tension; increased pulmonary vascular resistance index (PVRI), intrapulmonary shunting, and developed septicemia at the end of 6 hr experiment. iNO ameliorated the progressive hypoxemia and intrapulmonary shunting without affecting the PVRI. Only two of 8 animals with L-NAME pretreated pneumonia survived. Whereas when iNO was added to infected animals with L-NAME pretreatment, the progressive hypoxemia was abolished as a result of a decrease in intrapulmonary shunting without reverse of the high PVRI and systemic vascular resistance index induced by the L-NAME injection. This result suggests that a NOS blockade may be a possible supportive option for oxygenation by iNO treatment in neonatal Gram-negative bacterial pneumonia and sepsis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Scheme of the experimental protocol. L-NAME, administration of N-nitro-L-arginine methyl ester; E.coli/Saline, intratracheal instillation of Escherichia coli or Saline; iNO, administration of inhaled nitric oxide; Ventilator re-adjustment, Ventilator settings were changed to peak inspiratory pressure (PIP) 30 cmH2O, rate 25/min, peak end expiratory pressure (PEEP) 4 cmH2O, inspiratory time (IT) 0.6 sec. Animals in PNA were not included for the results because only two of eight survived. Measurement of variables was recorded hourly.
Fig. 2
Fig. 2
Mean systemic arterial pressure (MAP), mean pulmonary arterial pressure (PAP), mean systemic vascular resistance index (SVRI), mean pulmonary vascular resistance index (PVRI) and cardiac index in the newborn piglets of 4 groups at -1, 0, 3, and 6 hr of experiment. CON: control group; PCON: E. coli pneumonia control; PNO: E. coli pneumonia with 10 ppm nitric oxide inhalation; PNANO: E. coli pneumonia with added nitric oxide inhalation to L-NAME pretreatment (10 mg/kg). Data represent mean±standard deviation. *p<0.05 compared to CON, p<0.05 compared to PCON.
Fig. 3
Fig. 3
Arterial oxygen tension, carbon dioxide tension, intrapulmonary shunt fraction (venous admixture %) and Vd/Vt (dead space to tidal volume ratio) in the newborn piglets of 4 groups at 0, 3, and 6 hr of experiment. CON: control group; PCON: E. coli pneumonia control; PNO: E. coli pneumonia with 10 ppm nitric oxide inhalation; PNANO: E. coli pneumonia with added nitric oxide inhalation to L-NAME pretreatment (10 mg/kg). Data represent mean±standard deviation. *p<0.05 compared to CON, p<0.05 compared to PCON, p<0.05 compared to PNO.

Similar articles

Cited by

References

    1. Roberts JD, Jr, Fineman JR, Morin FC, 3rd, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM The Inhaled Nitric Oxide Study Group. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med. 1997;336:605–610. - PubMed
    1. Skimming JW, DeMarco VG, Cassin S. The effects of nitric oxide inhalation on the pulmonary circulation of preterm lambs. Pediatr Res. 1995;37:35–40. - PubMed
    1. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328:399–405. - PubMed
    1. Krafft P, Fridrich P, Fitzgerald RD, Koc D, Steltzer H. Effectiveness of nitric oxide inhalation in septic ARDS. Chest. 1996;109:486–493. - PubMed
    1. Holzmann A, Manktelow C, Taut FJ, Bloch KD, Zapol WM. Inhibition of nitric oxide synthase prevents hyporesponsiveness to inhaled nitric oxide in lungs from endotoxin-challenged rats. Anesthesiology. 1999;91:215–221. - PubMed

Publication types

MeSH terms